189 related articles for article (PubMed ID: 28820074)
1. Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor.
Clark JL; Taylor CG; Zahradka P
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):200-206. PubMed ID: 28820074
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease.
Takeuchi T; Adachi Y; Ohtsuki Y; Furihata M
Med Mol Morphol; 2007 Sep; 40(3):115-20. PubMed ID: 17874043
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis.
Fujishima Y; Maeda N; Matsuda K; Masuda S; Mori T; Fukuda S; Sekimoto R; Yamaoka M; Obata Y; Kita S; Nishizawa H; Funahashi T; Ranscht B; Shimomura I
FASEB J; 2017 Apr; 31(4):1571-1583. PubMed ID: 28062540
[TBL] [Abstract][Full Text] [Related]
4. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.
Hug C; Wang J; Ahmad NS; Bogan JS; Tsao TS; Lodish HF
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10308-13. PubMed ID: 15210937
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release.
Obata Y; Kita S; Koyama Y; Fukuda S; Takeda H; Takahashi M; Fujishima Y; Nagao H; Masuda S; Tanaka Y; Nakamura Y; Nishizawa H; Funahashi T; Ranscht B; Izumi Y; Bamba T; Fukusaki E; Hanayama R; Shimada S; Maeda N; Shimomura I
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669945
[TBL] [Abstract][Full Text] [Related]
6. Different spatiotemporal organization of GPI-anchored T-cadherin in response to low-density lipoprotein and adiponectin.
Balatskaya MN; Sharonov GV; Baglay AI; Rubtsov YP; Tkachuk VA
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129414. PubMed ID: 31404618
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the multiple roles of T-cadherin in health and disease.
Rubina KA; Semina EV; Kalinina NI; Sysoeva VY; Balatskiy AV; Tkachuk VA
Eur J Cell Biol; 2021; 100(7-8):151183. PubMed ID: 34798557
[TBL] [Abstract][Full Text] [Related]
8. Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin.
Kita S; Fukuda S; Maeda N; Shimomura I
Elife; 2019 Oct; 8():. PubMed ID: 31647413
[TBL] [Abstract][Full Text] [Related]
9. Cardiometabolic effects of adiponectin.
Parker-Duffen JL; Walsh K
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):81-91. PubMed ID: 24417948
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin/T-cadherin and apelin/APJ expression in human arteries and periadventitial fat: implication of local adipokine signaling in atherosclerosis?
Kostopoulos CG; Spiroglou SG; Varakis JN; Apostolakis E; Papadaki HH
Cardiovasc Pathol; 2014; 23(3):131-8. PubMed ID: 24675084
[TBL] [Abstract][Full Text] [Related]
11. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome.
Kita S; Maeda N; Shimomura I
J Clin Invest; 2019 Oct; 129(10):4041-4049. PubMed ID: 31483293
[TBL] [Abstract][Full Text] [Related]
12. An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways.
Adachi Y; Takeuchi T; Sonobe H; Ohtsuki Y
Virchows Arch; 2006 Mar; 448(3):311-8. PubMed ID: 16273386
[TBL] [Abstract][Full Text] [Related]
13. T-cadherin modulates endothelial barrier function.
Andreeva AV; Han J; Kutuzov MA; Profirovic J; Tkachuk VA; Voyno-Yasenetskaya TA
J Cell Physiol; 2010 Apr; 223(1):94-102. PubMed ID: 20039275
[TBL] [Abstract][Full Text] [Related]
14. T-cadherin is essential for adiponectin-mediated revascularization.
Parker-Duffen JL; Nakamura K; Silver M; Kikuchi R; Tigges U; Yoshida S; Denzel MS; Ranscht B; Walsh K
J Biol Chem; 2013 Aug; 288(34):24886-97. PubMed ID: 23824191
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats.
Asada K; Yoshiji H; Noguchi R; Ikenaka Y; Kitade M; Kaji K; Yoshii J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
Int J Mol Med; 2007 Nov; 20(5):725-9. PubMed ID: 17912467
[TBL] [Abstract][Full Text] [Related]
16. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
17. C1q tumor necrosis factor-related protein 9 in atherosclerosis: Mechanistic insights and therapeutic potential.
Yu XH; Zhang DW; Zheng XL; Tang CK
Atherosclerosis; 2018 Sep; 276():109-116. PubMed ID: 30056359
[TBL] [Abstract][Full Text] [Related]
18. Protective role of adiponectin in cardiovascular disease.
Shibata R; Murohara T; Ouchi N
Curr Med Chem; 2012; 19(32):5459-66. PubMed ID: 22876923
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin and end-stage renal disease.
Markaki A; Psylinakis E; Spyridaki A
Hormones (Athens); 2016 Jul; 15(3):345-354. PubMed ID: 27838604
[TBL] [Abstract][Full Text] [Related]
20. Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders.
Francischetti EA; Dezonne RS; Pereira CM; de Moraes Martins CJ; Celoria BMJ; de Oliveira PAC; de Abreu VG
Horm Metab Res; 2020 Oct; 52(10):695-707. PubMed ID: 32927496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
